Cargando…
Estrogen Receptor-α Quantification in Breast Cancer: Concordance Between Immunohistochemical Assays and mRNA-In Situ Hybridization for ESR1 Gene
Immunohistochemical (IHC) quantification of estrogen receptor-α (ER) is used for assessment of treatment regimen in breast cancer. Different ER IHC assays may produce diverging results, because of different antibody clones, protocols, and stainer platforms. Objective tissue-based techniques to asses...
Autores principales: | Thomsen, Christian, Nielsen, Søren, Nielsen, Boye S., Pedersen, Sine H., Vyberg, Mogens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253185/ https://www.ncbi.nlm.nih.gov/pubmed/30920963 http://dx.doi.org/10.1097/PAI.0000000000000760 |
Ejemplares similares
-
Proficiency testing in immunohistochemistry—experiences from Nordic Immunohistochemical Quality Control (NordiQC)
por: Vyberg, Mogens, et al.
Publicado: (2015) -
Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas
por: Nielsen, Sofie L., et al.
Publicado: (2017) -
Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
por: Vyberg, Mogens, et al.
Publicado: (2015) -
Lessons Learned, Challenges Taken, and Actions Made for “Precision” Immunohistochemistry. Analysis and Perspectives From the NordiQC Proficiency Testing Program
por: Nielsen, Søren, et al.
Publicado: (2023) -
Getting controls under control: the time is now for immunohistochemistry
por: Torlakovic, Emina Emilia, et al.
Publicado: (2015)